36 min listen
492: Investigating Novel Therapeutics to Improve Immune Function and Treat Age-Related Diseases - Dr. Joan Mannick
492: Investigating Novel Therapeutics to Improve Immune Function and Treat Age-Related Diseases - Dr. Joan Mannick
ratings:
Length:
37 minutes
Released:
Mar 11, 2019
Format:
Podcast episode
Description
Dr. Joan Mannick is Co-Founder and Chief Medical Officer of resTORbio, a clinical-stage biopharmaceutical company that develops novel therapeutics to treat aging-related diseases. Joan and her colleagues at resTORbio are targeting the biology of aging to treat and prevent aging-related diseases so people can be healthier longer. In particular, Joan is interested in targeting the aging immune system in an effort to reduce the risk of respiratory infections in older adults. After a busy day at work, Joan likes to relax by working out at the gym, watching movies, and reading novels. Joan received her B.A. from Harvard College and her M.D. from Harvard Medical School. She completed her residency in Internal Medicine at Brigham and Women’s Hospital and a fellowship in Infectious Disease at Harvard University. Joan then worked as a Medical Director at Genzyme and a faculty member at Harvard Medical School and the University of Massachusetts Medical School. Prior to joining resTORbio, Joan was Executive Director in the New Indications Discovery Unit of the Novartis Institutes of Biomedical research. In our interview Joan shares more about her life and science.
Released:
Mar 11, 2019
Format:
Podcast episode
Titles in the series (100)
002: Tackling Air Pollution - Dr. Ann Dillner: Dr. Ann Dillner is an Associate Research Engineer in the Crocker Nuclear Laboratory at the University of California – Davis. She received her Master of Mechanical Engineering degree from Stanford University and her PhD in Civil and Environmental... by People Behind the Science Podcast Stories from Scientists about Science, Life, Research, and Science Careers